Published in Clin Nephrol on April 01, 1986
Prostacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis in children. Arch Dis Child (1991) 0.96
Assessment of renal dopaminergic system activity during cyclosporine A administration in the rat. Br J Pharmacol (1995) 0.80
Prostacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis. Arch Dis Child (1992) 0.75
Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension (2000) 2.55
Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial. Lancet (1983) 1.94
Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter thrombocytometer. Platelets (2000) 1.64
Risk assessment of renal cortical scarring with urinary tract infection by clinical features and ultrasonography. Arch Dis Child (2000) 1.53
Renal venous thrombosis with calcification and preservation of renal function. Pediatr Radiol (2001) 1.53
Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet (1991) 1.50
Further evidence of increased polymorphonuclear cell activity in patients with Raynaud's phenomenon. Br J Rheumatol (1992) 1.50
Sonar and its use in kidney disease in children. Arch Dis Child (1972) 1.44
Foregut duplication cyst presenting as neonatal respiratory distress and haemoptysis. Thorax (1994) 1.42
Relationship between the extent of coronary artery disease and indicators of free radical activity. Clin Cardiol (1992) 1.39
Hypophosphatasia. J Clin Pathol (1996) 1.38
Impaired skin microvascular function in children, adolescents, and young adults with type 1 diabetes. Diabetes Care (2000) 1.36
Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant (1998) 1.19
Captopril: a free radical scavenger. Br J Clin Pharmacol (1989) 1.16
Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol (1990) 1.15
A prospective study of children with first acute symptomatic E. coli urinary tract infection. Early 99mtechnetium dimercaptosuccinic acid scan appearances. Acta Paediatr Scand (1989) 1.15
Accuracy of clean-catch urine collection in infancy. J Pediatr (1999) 1.14
Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J (1981) 1.10
Long-term assessment of cyclophosphamide therapy for nephrosis in children. Lancet (1974) 1.09
Pyuria and bacteriuria. Arch Dis Child (1967) 1.07
Haemophilia and the kidney: assessment after 11-year follow-up. Br Med J (Clin Res Ed) (1982) 1.06
Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial. Lancet (1983) 1.06
Increased prevalence of symptomatic macrovascular disease in systemic sclerosis. Ann Rheum Dis (1995) 1.04
Effects of gliclazide on platelet reactivity and free radicals in type II diabetic patients: clinical assessment. Metabolism (1992) 1.04
Clinical surveillance of thrombotic microangiopathies in Scotland, 2003-2005. Epidemiol Infect (2007) 1.04
Enhanced sensitivity of the peripheral cholinergic vascular response in patients with chronic fatigue syndrome. Am J Med (2000) 1.02
A comparative study using immunological and biological assay of the haemostatic responses to DDAVP infusion venous occlusion and exercise in normal men. Thromb Haemost (1984) 1.01
Cutaneous vascular responses to acetylcholine are mediated by a prostanoid-dependent mechanism in man. Vasc Med (1997) 1.01
Successful treatment of Raynaud's Syndrome with prostacyclin. Thromb Haemost (1981) 1.00
Childhood membranous nephropathy, circulating antibodies to the 58-kD TIN antigen, and anti-tubular basement membrane nephritis: an 11-year follow-up. Am J Kidney Dis (1998) 0.99
Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study. Br J Rheumatol (1998) 0.98
Nephrosonography in infants and children: a new technique. Br Med J (1972) 0.98
Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease. Br Heart J (1993) 0.98
Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int (1986) 0.98
Modulation of cellular immune function by cyclophosphamide in children with minimal-change nephropathy. N Engl J Med (1984) 0.98
The relationship of oxidative stress to thrombotic tendency in type 1 diabetic patients with retinopathy. Diabet Med (1991) 0.97
Assessment of microvascular endothelial function in human skin. Clin Sci (Lond) (2001) 0.96
The effects of acute smoking on platelet behaviour, fibrinolysis and haemorheology in habitual smokers. Thromb Haemost (1984) 0.96
A comparison of the free radical scavenging activity of leukotrienes and prostaglandins. Free Radic Res Commun (1988) 0.96
Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynaud's syndrome. Prostaglandins Leukot Med (1985) 0.96
The effects of intravenous ZK36-374, a stable prostacyclin analogue, on normal volunteers. Prostaglandins (1984) 0.95
Skin blood flow changes in response to intradermal injection of bupivacaine and levobupivacaine, assessed by laser Doppler imaging. Reg Anesth Pain Med (2001) 0.94
Neonatal nephrocalcinosis: long term follow up. Arch Dis Child Fetal Neonatal Ed (2006) 0.94
Oral L-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud's phenomenon. Arthritis Rheum (1997) 0.94
Molecular and genetic aspects of preeclampsia: state of the art. Mol Genet Metab (2000) 0.93
Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon. Ann Rheum Dis (1993) 0.93
The value of ultrasound in the child with an acute urinary tract infection. Br J Urol (1994) 0.92
Complement activation in Henoch-Schönlein purpura. Pediatr Nephrol (1997) 0.92
Lipid-lowering and skin vascular responses in patients with hypercholesterolaemia and peripheral arterial obstructive disease. Vasc Med (1999) 0.91
Cholelithiasis associated with hemolytic uremic syndrome. Clin Nephrol (1991) 0.91
Detection of microvascular impairment in type I diabetics by laser Doppler flowmetry. Clin Physiol (1992) 0.91
Antibiotic susceptibility of staphylococci from CAPD peritonitis in children. J Antimicrob Chemother (1987) 0.91
Renal venous thrombosis in infancy: long-term follow-up. Pediatr Nephrol (1991) 0.91
Pseudomembranous colitis in association with Henoch Schonlein purpura. Scott Med J (1988) 0.90
Influence of puberty on endothelial dysfunction and oxidative stress in young patients with type 1 diabetes. Diabetes Care (1998) 0.90
Alternative mechanisms for the hypotensive effects of adrenergic blockade. Br Med J (Clin Res Ed) (1983) 0.90
Blood viscosity in young male diabetics with and without retinopathy. Diabetologia (1980) 0.89
Fungal peritonitis in children on continuous ambulatory peritoneal dialysis. Scott Med J (1989) 0.89
Neonatal ascites from spontaneous rupture of the bladder. Arch Dis Child (1975) 0.89
Human whole-blood granulocyte aggregation in vitro. Clin Sci (Lond) (1989) 0.89
Mitochondrial mutation as a probable causative factor in familial progressive tubulointerstitial nephritis. Hum Genet (1997) 0.88
Lipid peroxidation during myocardial ischaemia induced by pacing. Br Heart J (1990) 0.88
Cigarette smoking increases white blood cell aggregation in whole blood. J R Soc Med (1993) 0.88
Skin perfusion in patients with erythromelalgia. Eur J Clin Invest (1999) 0.88
Plasma fibrinopeptide A and beta-thromboglobulin in pre-eclampsia and pregnancy hypertension. Thromb Haemost (1982) 0.87
Use of rapamycin in a transplant patient who developed cyclosporin neurotoxicity. Pediatr Nephrol (2001) 0.87
A circadian variation exists for soluble levels of intercellular adhesion molecule-1 and E-selectin in healthy volunteers. Clin Sci (Lond) (1998) 0.86
DDAVP stimulates prostacyclin production. Thromb Haemost (1982) 0.86
Combined phlebography and arthrography in patients with painful swollen calf. Br Med J (Clin Res Ed) (1981) 0.86
Dopamine hydrochloride in oliguric states. Lancet (1980) 0.86
White blood cell activation in Raynaud's phenomenon of systemic sclerosis and vibration induced white finger syndrome. Ann Rheum Dis (1992) 0.86
The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double blind study of stanozolol. Q J Med (1986) 0.86
Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis--a double-blind placebo controlled study. Br J Rheumatol (1993) 0.86
Haemolytic uraemic syndrome: 17 years' experience in a Scottish paediatric renal unit. Scott Med J (1991) 0.86
Gliclazide: a general free radical scavenger. Eur J Pharmacol (1991) 0.86
Exercise in patients with intermittent claudication results in the generation of oxygen derived free radicals and endothelial damage. Adv Exp Med Biol (1994) 0.85
Children of renal transplant recipient mothers. J Paediatr Child Health (2000) 0.84
Soluble cell adhesion molecules--P-selectin and ICAM-1, and disease activity in patients receiving sulphasalazine for active rheumatoid arthritis. Scand J Rheumatol (1998) 0.84
Cutaneous vascular responses and thermoregulation in relation to age. Clin Sci (Lond) (1992) 0.84
Endothelial activation and response in patients with hand arm vibration syndrome. Eur J Clin Invest (1999) 0.84
Circadian variation of white blood cell aggregation and free radical indices in men with ischaemic heart disease. Eur Heart J (1992) 0.84
Behçet's syndrome presenting as myocardial infarction with impaired blood fibrinolysis. Br Heart J (1984) 0.84
Increased blood viscosity in diabetic proliferative retinopathy. Diabetes Res (1986) 0.84
Free radical scavenging activity of sulfonylureas: a clinical assessment of the effect of gliclazide. Metabolism (2000) 0.84
Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency. J Clin Endocrinol Metab (2001) 0.83
Prostacyclin infusion in haemolytic-uraemic syndrome of children. Br Med J (Clin Res Ed) (1981) 0.83
Oxidative damage in chronic heart failure: protection by captopril through free radical scavenging? Adv Exp Med Biol (1990) 0.83
Endothelin-1 gene and endothelial nitric oxide synthase gene polymorphisms in adolescents with juvenile and obesity-associated hypertension. Acta Physiol Hung (2007) 0.83
Age, sex, cigarette smoking and indices of free radical activity in healthy humans. Eur J Med (1993) 0.83
Decreased plasma fibrinolysis in patients with rheumatoid arthritis. Ann Rheum Dis (1984) 0.83
Impaired skin vasomotor reflexes in patients with erythromelalgia. Clin Sci (Lond) (1999) 0.82